Why now?

Sleep apnea is a serious cardiac threat that needs fast solutions

More than 50% of all cardiology patients, including at least one in two AFib patients, suffer from sleep apnea—a severely underdiagnosed condition that can put their lives risk.1-5

The alarming consequences of sleep apnea4-7
2x the risk of stroke
2x the risk of sudden cardiac death
5x the risk of cardiovascular mortality
57% increased risk of AFib recurrence after ablation

It is unequivocally clear that we are not effectively treating our patients with AF unless we screen them for sleep apnea.

—Dr. Larry Chinitz, MD, a leading US cardiologist in New York with 39 years of experience and specialties including clinical cardiac electrophysiology and internal medicine
IM-C-quote LarryAsset 33@2x

Why not?

WatchPAT® ONE is part of the WatchPAT® TurnKey solution—a remote sleep apnea diagnostic and treatment program designed specifically for cardiology practices.
Fast, easy, and seamless—you prescribe the test, we can do the rest:

Why wait?

The award-winning, fully disposable WatchPAT® ONE HSAT delivers accurate,8 comprehensive sleep study results without delay—so you can help expedite the pathway to personalized, optimized care.
IM-C-instantAsset 36@2x

Instant results*

*Within minutes of study completion.

IM-C-fullyAsset 37@2x

Fully disposable

IM-C-easyAsset 38@2x

Easy to use

Sign up now for your FREE sample of state-of-the-art WatchPAT® ONE.

See it for yourself, and use it to educate your staff and patients.

Just ONE thing to do: complete this form

For US customers only.

Facebook
Twitter
LinkedIn

References: 1. Seet E, Chung F. Obstructive sleep apnea: preoperative assessment. Anesthesiology Clin. 2010;28(2):199-215. https://doi.org/10.1016/j.anclin.2010.02.002. 2. Ayache MB, Mehra R, Mayuga KA. 1-minute consult: brief answers to specific clinical questions. Clevel Clin J Med. 2019:86:709-712. 3. Heart Rhythm Society. Atrial  brillation and sleep apnea: what you need to know. https://www.hrsonline.org/documents/atrial- brillation-and-sleep-apnea/download. Accessed June 1, 2021. 4. Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin Sleep Cohort. SLEEP. 2008;31(8):1071-1078. 5. Gami AS, Olson EJ, Shen WK, et al. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol. 2013;62(7):610-616. 6. Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea-hypopnea and incident stroke: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2010;182:269-277. 7. Li L, Wang Z-w, Li J, et al. E cacy of catheter ablation of atrial  brillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies. Europace. 2014;16:1309-1314. 8. Yalamanchali S, Farajian V, Hamilton C, Pott TR, Samuelson CG, Friedman M. Diagnosis of obstructive sleep apnea by peripheral arterial tonometry: metaanalysis. JAMA Otolaryngol Head Neck Surg. 2013;139(12):1343-1350. doi:10.1001/jamaoto.2013.5338.

 

Your information will be handled in accordance with our privacy policy.

This material is subject to a disclaimer available here.

When using the marks in our publications and this website, we used the appropriate ™, ℠, or ®. The ® symbol is used to indicate registrations in the U.S. and the territories listed in https://www.itamar-medical.com/terms-and-conditions/, and this should not mean that such trademarks are necessarily registered in other countries. For example, WatchPAT®  is a trademark of Itamar Medical Ltd., registered in the U.S. and the applicable territories listed in https://www.itamar-medical.com/terms-and-conditions/ only.

WatchPAT® and PAT® are trademarks of Itamar Medical Ltd. Copyright © 2021 by Itamar Medical Ltd. All rights reserved.